Vermont’s Next Act: Wholesale Prescription Drug Importation Program
With Vermont Governor Phil Scott’s (R) signature on Senate Bill 175, Vermont now becomes the first-in-the-nation to enact a…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
May 2018
Fresenius Provides Insight As to Why It Terminated Acquisition of Akorn,…
On Wednesday, May 2, 2018, Fresenius made some allegations that shed light on why the company sought to terminate its acquisition…
Florida Passes Legislation Regarding Mandatory CME for Prescribers
On March 20, 2018, Florida Governor Rick Scott signed into law the legislation that is now Florida Statute 456.0301. This new law…
Off-Label Promotion: Tennessee Becomes Second State to Allow Pharmaceutical…
Tennessee becomes the second state in the country permitting pharmaceutical companies, including its representatives, to engage in…
President Trump Gives Remarks on Lowering Drug Prices
“We will see those prices go down, it will be a beautiful thing to watch.” President Donald J. Trump
In less than twenty-five…
Opioid Class Action Suit Filed in Five States
On May 2, 2018, three law firms filed class action lawsuits against pharmaceutical manufacturers and distributors on behalf of…
Growth Rate of Spending on Medicine Slows
The IQVIA Institute for Human Data Science recently released a report focused on net spending on medicines in the United States in…
CMS Announces Medicare Data Roll-Out
On Thursday, April 26, 2018, Centers for Medicare and Medicaid Services Administrator Seema Verma announced the Agency’s new Data…
Oklahoma Requires CME for Prescribers
Many states have taken the cue from the federal government and started their own investigation and research into opioids and the…
House Introduces Bill to Require CME for Controlled Substance Prescribing
House of Representatives member Representative Susan W. Brooks recently introduced the ADAPT Act of 2018. The ADAPT Act (Abuse…